NPI: 1609830744 · PASCO, WA 99301 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,796 | $933K |
| 2019 | 30,061 | $946K |
| 2020 | 27,386 | $666K |
| 2021 | 23,760 | $420K |
| 2022 | 25,432 | $690K |
| 2023 | 15,651 | $829K |
| 2024 | 6,393 | $632K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 58,677 | 3,854 | $3.54M |
| A4657 | Syringe, with or without needle, each | 6,968 | 3,047 | $1.27M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 38,989 | 2,364 | $169K |
| J1756 | Injection, iron sucrose, 1 mg | 10,655 | 2,430 | $52K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 883 | 438 | $50K |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,033 | 1,828 | $19K |
| 90674 | 143 | 114 | $6K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 147 | 37 | $2K |
| G0008 | Administration of influenza virus vaccine | 190 | 154 | $106.17 |
| 82108 | 141 | 103 | $0.00 | |
| 83540 | 2,030 | 1,453 | $0.00 | |
| 83970 | 2,769 | 2,003 | $0.00 | |
| 90662 | 50 | 44 | $0.00 | |
| 85041 | 2,420 | 1,776 | $0.00 | |
| 85048 | 2,399 | 1,758 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 78 | 26 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 374 | 278 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 912 | 440 | $0.00 |
| 82728 | 2,004 | 1,445 | $0.00 | |
| 83550 | 1,617 | 1,228 | $0.00 |